摘要
为研究苦楝皮的化学成分及其抗糖尿病活性,采用正相、反相及Sephadex LH-20凝胶柱色谱等方法分离纯化化合物,通过波谱数据和理化性质分别鉴定为12β,20(S)-dihydroxydammar-24-en-3one(1),dammarendiol Ⅱ3-0-caffeate(2),24-methylenecyclosnenone(3),meliavolin(4),3,20-diacetyl-11-methoxy-1-tigloylmeliacarpinin(5),methyl3-formyl-2,4-dihydroxy-6.methylbenzoate(6),usnicacid(7),epi-catechin(8)。其中化合物1~3,6,7均为首次从该植物中分离得到。采用酶偶联、液闪接近测定等技术测试化合物2~5体外抗糖尿病活性。研究结果表明,受试化合物2~5均未表现出GK、SIRTl体外激动活性和DPPIV抑制活性,但化合物2对人11β-HSD1具有显著的抑制作用(IC50=94.15nmol/L)。
The chemical constituents from the barks of Melia azedarach were isolated by silica gel, reverse phase silica gel and Sephadex LH-20 column chromatography, and their anti-diabetes activities were subsequently evaluated. Eight compounds were obtained and elucidated as 12β,20 (S)-dihydroxydammar-24-en-3-one (1), dammarendiol II 3-O-caf- feate(2) ,24-methylenecycloartenone(3 ), meliav.olin (4) ,3,20-diacetyl-11-methoxy- 1-tigloylmeliacarpinin (5), methyl 3-formyl-2,4-dihydroxy-6-methyl benzoate (6), usnic acid (7) and epi-catechln (8) based on their spectra and physio- chemical characteristics. Among these, compounds 1-3,6, and 7 were isolated from this species for the first time. All the tested compounds 2-5 were inactive against GK, SIRT1 and DPPIV, but compounds 2 showed significant inhibitory activi- ty against human 11β-HSD1 with IC50 value of 94.15 nmol/L.
出处
《天然产物研究与开发》
CAS
CSCD
北大核心
2014年第2期162-166,共5页
Natural Product Research and Development
基金
973计划前期研究专项(2011CB512005)
国家自然科学基金项目(81360477)
国家重点实验室培育基地-广西壮族自治区药用资源化学与药物分子工程重点实验室基金项目(CMEMR2012-B05)
2012年度广西高等学校优秀人才资助计划